FDA Releases New Strategic Plan for Risk Communication

On September 30, the Food and Drug Administration issued its Strategic Plan for Risk Communication, “…which outlines the agency’s efforts to disseminate more meaningful public health information.”
On September 30, the Food and Drug Administration issued its Strategic Plan for Risk Communication, “…which outlines the agency’s efforts to disseminate more meaningful public health information.”  Psychologists have been crucial to annunciating the role of science in the plan serving both as FDA staff and as outside experts.  Dr. Baruch Fischhoff has chaired FDA’s Risk Communication Advisory Committee (RCAC) since its inception in 2007.  Dr. Ellen Peters, who recently rotated off RCAC, and Dr. Craig Anderson, whose term runs through 2012, also contributed substantively during the committees deliberations.  Psychologist, Dr. Nancy Ostrove, FDA’s Director for Risk Communication, provided stewardship as the draft plan, released last April, wended its way through FDA to fruition last month.  Organized as a series of science, capacity and policy strategies, the plan is a remarkable endorsement for the role of behavioral science in FDA’s current approach to risk communication, as well as its commitment to strengthening the science for effective risk communications in the future.